The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Cherilyn Radbourne - TD Cowen - Analyst
: Thanks very much and good morning. First question is apart from semiconductors and pharmaceuticals. I find that investors I speak with are
somewhat skeptical about the concept of broad re-industrialization in the US. Could you elaborate a little bit more on Brookfield's perspective on
that and the opportunity to use the Intel deal as a template to facilitate the related funding needs?
Question: Cherilyn Radbourne - TD Cowen - Analyst
: Thank you. And secondly, we appreciate the enhanced disclosure on Brookfield's Wealth Solutions. And one question that I have in that regard is
with respect to funding agreements for the source of funds, can you explain how the characteristics of that liability differ versus straight up annuities
and pension risk transfer deals and who is the typical counterparty there?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MAY 08, 2025 / 2:00PM, BN.N - Q1 2025 Brookfield Corp Earnings Call
Question: Cherilyn Radbourne - TD Cowen - Analyst
: That's really helpful. Thank you.
Question: Michael Cyprys - Morgan Stanley - Analyst
: Hey, good morning. Thanks for taking the questions. Maybe just starting off on Wealth Solutions and greatly appreciate the enhanced disclosure
there. So big thank you. So just around the $25 billion of business you expect to do in calendar '21, I think you did maybe around $4 billion this
quarter, so that would suggest a meaningful ramp over the next couple of quarters.
So I was hoping you could elaborate a bit on where you see that coming from what you see contributing there to drive the ramp -- and then related
to that, you spoke about building out the distribution and product side as well. Maybe you could just speak to how you anticipate that playing out
just around the distribution channels. Maybe remind us where you are today and how you expect the product set to evolve from here? Thank you.
Question: Michael Cyprys - Morgan Stanley - Analyst
: Great, thank you. And then just a follow-up question on real estate. Maybe you could talk for a moment just how you're approaching and thinking
about the opportunity set in this more volatile backdrop to monetize the real estate portfolio, how you expect that to -- the cadence of that to play
out over the next 12 months versus the next five years? Thank you.
Question: Michael Cyprys - Morgan Stanley - Analyst
: Great, thank you.
Question: Kenneth Worthington - JPMorgan - Analyst
: Hi, good morning. Thanks for taking the questions. Along the same lines, Nick, Bruce both highlighted that carry generation sort of at the highest
level in two years. The pace of monetization's, $22 billion was strong and maybe a somewhat uneven environment. What does the monetization
pipeline look like as we think about the second half of the year? And maybe compare the outlook for monetization's in the funds versus what you
see potentially off the balance sheet?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MAY 08, 2025 / 2:00PM, BN.N - Q1 2025 Brookfield Corp Earnings Call
Question: Kenneth Worthington - JPMorgan - Analyst
: Okay. Great. And then maybe secondly, the US financial media is suggesting another larger annuity companies in play for takeout by private equity.
So just sort of gets to the question, how beneficial is additional size and scale completely irrelevant to this company.
But how much -- how beneficial is additional size and scale to Brookfield given your current position? Is it nice to have at the right price? Is it a
must-have given the marketplace is consolidating? Or is it really sort of irrelevant, given what you've already built?
Question: Kenneth Worthington - JPMorgan - Analyst
: Great. Thank you.
| 
